PT-141 10mg

Description

PT-141 (Bremelanotide) Peptide Overview

PT-141, also known as bremelanotide, is a synthetic cyclic peptide and melanocortin-receptor agonist derived from the peptide Melanotan II. Unlike pigment-focused analogs, PT-141 is studied in research for its action on central nervous-system melanocortin pathways.

Melanocortin Receptor Activation

PT-141 activates melanocortin receptors, primarily MC4R and MC1R. Its research interest centers on MC4R signaling in the central nervous system rather than peripheral pigmentation.

Central Arousal Pathway Research

The most studied aspect of PT-141 is its effect on hypothalamic melanocortin pathways involved in arousal and sexual-response signaling, investigated in neurobehavioral research models.

Distinct Mechanism

Because PT-141 acts through central neural pathways rather than the vascular system, it represents a distinct mechanism of interest in melanocortin research.

Specifications

• CAS Number: 189691-06-3
• Molecular Formula: C50H68N14O10
• Molar Mass: 1025.16 g/mol
• Class: Melanocortin (MC4R/MC1R) receptor agonist (cyclic heptapeptide)
• Storage: Refrigerate after reconstitution.
• Form: Lyophilized powder in a sterile glass vial.
• Purity: Minimum 99%
• Quantity: 10mg per vial
• Color: White

Important Note: This product is intended solely for in vitro laboratory research by licensed professionals. It is not approved by the FDA for human or animal use and should not be misbranded, misused, or mislabeled as a drug, food, supplement, or cosmetic.

References:

1. Molinoff P.B. et al. – PT-141: a melanocortin agonist for research – Annals of the New York Academy of Sciences
2. Bremelanotide and the melanocortin-4 receptor – Journal of Sexual Medicine
3. Central melanocortin signaling – Pharmacological Reviews